Hoth Therapeutics announces positive preclinical results for HT-KIT in aggressive cancer gastrointestinal stromal tumours: New York Wednesday, March 19, 2025, 18:00 Hrs [IST] Hoth ...

Cogent Biosciences, Inc. (Nasdaq: COGT), a biotechnology company focused on developing precision therapies for genetically defined diseases, today announced four preclinical poster presentations at ...

ESR1 gene mutations are known to be linked to hormone receptor-positive (HR+) metastatic breast cancer. The research-use-only assay, which includes a qPCR detection kit and an isolation kit for ...

You have full access to this article via your institution. Figure 1: A family with multiple GISTs and mutation of the KIT gene.

Under the guidance of instructor Connie Briehn, Advanced Placement  Biology students from St. Bernard Preparatory School ...

Scientists say a concerning genetic mutation has appeared in H5N1 bird flu infected cats living in a New Jersey suburb of New ...